NCT02674880View on ClinicalTrials.gov

Hyaluronic Acid in Acute Exacerbation of COPD - Duration Of Noninvasive Assistance

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

September 30, 2019

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

HMW-HA

Aerolized administration b.i.d.

OTHER

Placebo

Standard therapy

Trial Locations (1)

00128

Università Campus Biomedico di Roma, Roma

All Listed Sponsors
collaborator

National Institute of Environmental Health Sciences (NIEHS)

NIH

lead

Campus Bio-Medico University

OTHER

NCT02674880 - Hyaluronic Acid in Acute Exacerbation of COPD - Duration Of Noninvasive Assistance | Biotech Hunter | Biotech Hunter